세툭시맙

세툭시맙 화학적 특성, 용도, 생산

• Originator

  ImClone (US)

• 용도

  Treatment of EGF receptor-expressing cancers (monoclonal antibod.

• 상표명

  Erbitux

• Mechanism of action

  Cetuximab, a monoclonal antibody, binds to the extracellular domain of the EGFR, which is overexpressed in many human cancers, including head, neck, and colorectal types. This process prevents the EGFR from binding with its endogenous ligand, blocking the receptor-dependent transduction pathway and providing many antitumor effects involving cell-cycle arrest, induction of apoptosis, inhibition of angiogenesis, inhibition of metastasis, internalization, and downregulation of the EGFR, and enhancement of the sensitivity to radiochemotherapy[1].
  

• Toxicology

  The majority of skin toxicities were mild to moderate, symptomatic treatments were effective in controlling them. The skin discomfort caused by cetuximab can affect the quality of life temporarily; with long term treatment, severity of skin toxicity may decrease.

• 참고 문헌

  [1] W Bou-Assaly, S Mukherji. “Cetuximab (erbitux).” American Journal of Neuroradiology 31 4 (2010): 626–7.

세툭시맙 공급 업체

Global(167)Suppliers

세툭시맙 관련 검색